Ausbiotech National Conference 2011

Last year's summit attracted over 150 investors from around the world to hear about the 40 selected Australian biotechnology companies, achieving its goal of showcasing Australia's world-class R&D, late-stage and emerging companies.

One of AusBiotech’s priorities is to stimulate and support investment in Australia’s biotechnology innovation. One of the most effective ways to achieve this is to develop and manage independent investor meetings that ensure access for the Australian industry to global life science investors, a task even more important in these times of economic duress.

The presenting companies will be a mix of listed companies in late-stage development, private companies with identified product/opportunities and early-stage commercialisation companies from research institutes and universities.